Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2007
03/30/2007CA2560161A1 Production of recombinant human collagen
03/29/2007WO2007035930A2 Glycosylated polypeptides produced in yeast mutants and methods of use thereof
03/29/2007WO2007034809A1 Host cell for producing recombinant protein
03/29/2007WO2007034782A1 Recombinant vector capable of increasing secretion of koji mold protease
03/29/2007WO2007034497A2 Secure data transmission
03/29/2007WO2007012614A3 Novel anti-igf-ir antibodies and uses thereof
03/29/2007WO2007009946A3 Process for the manufacture of eptifibatide
03/29/2007WO2006138225A3 A novel and practical serological assay for the clinical diagnosis of leishmaniasis
03/29/2007WO2006128084A3 Trps1-mediated modulation of hair growth
03/29/2007WO2006121810A3 Trimeric ox40-immunoglobulin fusion protein and methods of use
03/29/2007WO2006121664A3 Polypeptides for inducing a protective immune response against staphylococcus aureus
03/29/2007WO2005074524A3 Modified human interferon polypeptides and their uses
03/29/2007WO2005053811A3 Biomolecule partition motifs and uses thereof
03/29/2007WO2005035730A3 Dna sequences of the botulinum neurotoxin complex of type a-hall (allergan) strain
03/29/2007WO2004081197A3 Immune response associated proteins
03/29/2007US20070074305 nucleic acid molecule comprising a first nucleic acid segment encoding a polypeptide, and a second nucleic acid segment for suppression of a polypeptide involved in altering oleic acid content in a plant cell
03/29/2007US20070074296 RTD receptor
03/29/2007US20070074295 Schizophrenia related gene
03/29/2007US20070073048 Hiv polynucleotides and polypeptides derived from botswana mj4
03/29/2007US20070073047 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics
03/29/2007US20070073043 Process for producing humanized chimera antibody
03/29/2007US20070073041 Human tumor necrosis factor receptor polypeptides
03/29/2007US20070072797 Epitopes
03/29/2007US20070072794 Novel genes and proteins encoded thereby
03/29/2007US20070072271 Method for the production of recombinant proteins
03/29/2007US20070072270 PS4 variant with a proline substitution, derivable from a parent polypeptide, having non-maltogenic exoamylase activity; higher thermostability compared to the parent polypeptide
03/29/2007US20070072269 Ubiquitin-specific protease occurring in the brain and DNA encoding the same
03/29/2007US20070072268 Sulfotransferase and DNA encoding the enzyme
03/29/2007US20070072267 Transformant having galactose induction system and use thereof
03/29/2007US20070072266 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof
03/29/2007US20070072265 Expression vector comprising nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) proteins for enhancing production of functional heterologous polypeptides
03/29/2007US20070072264 Recombinant chimeric acetylcholine receptors and their derivatives recognized by cd4 t cells of myasthenic patients for the treatment of myasthenia gravis
03/29/2007US20070072263 DNA19355 polypeptide, a tumor necrosis factor homolog
03/29/2007US20070072262 Deletions inactivate arginine and histidine biosynthetic pathways in methylotrophic yeast (Pichia pastoris); arginiosuccinate synthase (ARG1); amino-acid N-acetyltransferase (ARG2), ornithine carbamoyltransferase (ARG3), ATP phosphoribosyltransferase (HIS1), histidinol-phosphatase (HIS2)
03/29/2007US20070072261 Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof
03/29/2007US20070072260 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders
03/29/2007US20070072259 Fluorescent protein
03/29/2007US20070072249 Human cytokine and alpha-helix-containing polypeptides
03/29/2007US20070072247 Methods and reagents for the analysis and purification of polysaccharides
03/29/2007US20070072239 Pharmaceutical compositions and methods of using secreted frizzled related protein
03/29/2007US20070072238 Wnt-frizzled chimera
03/29/2007US20070072231 Tumor suppressor gene
03/29/2007US20070072225 Antibodies with simultaneous subsite specificities to protein and lipid epitopes
03/29/2007US20070072218 A polynucleotide encoding a polypeptide having the amino acid sequence of SEQ ID NO:1, sequence operably linked to a heterologous promoter selected from hsp68, SV40, CMV, GAL4UAS, HSV and beta -actin; anticarcinogenic agents
03/29/2007US20070072217 XAF genes and polypeptides: methods and reagents for modulating apoptosis
03/29/2007US20070072202 toll-like receptors; lipoproteins
03/29/2007US20070072200 useful in screening for small molecule inhibitors of X4 vs R5 viruses, for focusing antiviral therapies based on the predominant or exclusive type of HIV-1 virus present (X4 vs R5) and for creating templates for rational vaccine design
03/29/2007US20070072186 Methods and agents for screening for compounds capable of modulating her2 expression
03/29/2007US20070072185 Carbohydrate-binding modules of a new family
03/29/2007US20070072183 Topoisomerase hybrids and methods of use
03/29/2007US20070071774 Protein D - an IgD-binding protein of Haemophilus influenzae
03/29/2007US20070071767 Polypeptides used for induction of cytotoxic T lymphocytes or activation of human leukocyte antigens (HLA), administered as anticarcinogenic vaccines; immunology
03/29/2007US20070071759 Antibody-immune cell ligand fusion protein for cancer therapy
03/29/2007US20070071755 Novel nucleolar GTPases and method for controlling proliferation of cells
03/29/2007US20070071752 Sphingosine kinase enzyme
03/29/2007US20070071751 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
03/29/2007US20070071750 Comprises heavy and light chain; treating envenomation by administering to neutralize in vivo effect
03/29/2007US20070071744 Agents which bind to epitopes of glycoprotein VI
03/29/2007US20070071743 Novel human cell surface protein with immunoglobulin folds, BGS-19
03/29/2007US20070071742 bind ICAM-1 and inhibit pathogen infection of cells expressing ICAM-1; for protection against human rhinovirus (HRV), coxackie A virus, respiratory syncytial virus (RSV), or malaria
03/29/2007US20070071741 OCL-2A3 compositions and uses thereof
03/29/2007US20070071724 Methods for increasing learning and memory in amyloid-beta-related neurodegenerative disorders by increasing Uch-L1 activity and methods for identifying enhancers of Uch-L1 activity
03/29/2007US20070071719 Compositions and methods for regulation of tumor necrosis factor-alpha
03/29/2007US20070071714 Stem cell factor
03/29/2007US20070071675 Engineered multivalent and multispecific binding proteins; treatment of acute and chronic inflammatory, cancer
03/29/2007US20070071674 Polynucleotides encoding novel isoforms of IGSF9
03/29/2007CA2623176A1 Protein a production and purification without using animal derived components
03/28/2007EP1767645A1 Transglycosylation method and method for producing glycoprotein
03/28/2007EP1767640A1 Process for producing protein a-like protein with use of brevibacillus genus bacaterium
03/28/2007EP1767639A1 Oral vaccine against protozoiasis using genetically modified plant
03/28/2007EP1767638A2 Mutation associated with epilepsy
03/28/2007EP1767637A1 Mutation associated with epilepsy
03/28/2007EP1767635A1 Fluorescent protein
03/28/2007EP1767629A2 Methods for the detection, analysis and isolation of nascent proteins
03/28/2007EP1767628A1 Process for producing dipeptides or dipeptide derivatives
03/28/2007EP1767627A1 Anti-perp antibody
03/28/2007EP1767625A1 Activity regulator for interferon producing cell
03/28/2007EP1767543A1 Novel bee venom polypeptides and methods of use thereof
03/28/2007EP1767103A2 Porphyrin containing lactic acid bacterial cells and use thereof
03/28/2007EP1766388A2 Stable isotope labeled polypeptide standards for protein quantitation
03/28/2007EP1766098A2 Rabbit monoclonal antibodies to hepatitis b surface antigens and methods of using the same
03/28/2007EP1766040A2 Methods for transforming and expression screening of filamentous fungal cells with a dna library
03/28/2007EP1766039A2 Methods of making nanotechnological and macromolecular biomimetic structures
03/28/2007EP1766015A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
03/28/2007EP1766000A1 Improved methods of producing heterologous proteases
03/28/2007EP1765996A2 Mammalian endonucleases and methods of use
03/28/2007EP1765994A2 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof
03/28/2007EP1765993A2 Truncated st6galnaci polypeptides and nucleic acids
03/28/2007EP1765854A1 An expression system comprising operably linked rgg gene and gtfg promoter
03/28/2007EP1765418A2 Method for enhancing production of isoprenoid compounds
03/28/2007EP1765386A2 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same
03/28/2007EP1765316A2 Methods and compositions for modulating bax-ku70-mediated apoptosis
03/28/2007EP1403371B1 Polypeptide having a cell death inhibitory activity
03/28/2007EP1309604B1 Phage-dependent superproduction of biologically active protein and peptides
03/28/2007EP0815246B1 Methods and compositions for secretion of heterologous polypeptides
03/28/2007CN1938425A Process for producing dipeptides
03/28/2007CN1936014A H5 subtype highly pathogenic avian influenza virus hemagglutinin gene antigen protein
03/28/2007CN1936009A Avian influenza virus matrix protein and nucleoprotein fusion antigen protein expression preparation
03/28/2007CN1935996A H9 subtype highly pathogenic avian influenza virus hemagglutinin gene antigen protein
03/28/2007CN1935995A H7 subtype highly pathogenic avian influenza virus hemagglutinin gene antigen protein